RECENT NEWS

PACE (Pathways to Antimicrobial Clinical Efficacy) has announced a partnership with the UK Health Security Agency (UKHSA) to support innovators developing new antimicrobials.

Registration for the 2024 SHOT Symposium is now open. The event will be held on Tuesday, 9 July 2024 at the Mercure Manchester Piccadilly Hotel.

The NHS is offering routine preventative bowel cancer screening to thousands of people in England with a genetic condition that increases their chance of developing certain cancers. This is a world-first move by the health service to help reduce cases and identify bowel cancers earlier when successful treatment and cure is more likely.

MIP Discovery, a developer of non-biological affinity reagents designed to accelerate the development and production of cell and gene therapies, has closed a £7 million Series A financing round. The investment marks a pivotal change for MIP Discovery as the Bedfordshire-based company refocuses its mission on improving the downstream processing of cell and gene therapies, to accelerate widespread adoption of these potentially life-changing medicines.

Using gene editing proteins combined with nanopore sensing technology, new research shows that testing for mpox pathogens could become faster and more accessible.

A new group has been formed by the UK Approved Bodies for certifying medical devices, with 11 companies joining forces as Team-AB (The UK Association for Medical Device Approved Bodies).

UK patients want better access to early and accurate diagnosis of health problems, according to new survey data from the Patients Association. Nine in ten (90%) of UK patients say it should be more straightforward to get the diagnostic tests they need.

NHS Grampian has launched a pilot scheme aimed at diagnosing bloodborne viruses (BBVs) earlier – which improves outcomes and treatment options for patients. Early detection of hepatitis B, hepatitis C and HIV can be lifesaving, as they are treatable. But if left untreated they can lead to serious illness and death.

Alpha Laboratories has introduced the latest advancement in faecal calprotectin extraction workflows. The CALEX Faecal Calprotectin Collection Kit is an innovative solution that enables patients to prepare and return their samples, revolutionising the traditional stool testing process. Stabilised samples arrive in the laboratory ready for processing and analysis.

Advanced Instruments, a provider of analytical instruments and services for clinical and biopharmaceutical laboratories is delighted to welcome Jo Felix to the team as Key Account Manager for the Clinical Portfolio in the United Kingdom.

As part of a £10 million funding package for boosting access to medical technology, eight innovative technology companies will be supported by the UK Government to bring their devices to market. New blood tests for identifying stroke patients and Alzheimer’s disease are two of the innovations to be supported.

OGT, a leading global provider of genomic research and diagnostic solutions, has announced the opening of state-of-the-art facilities within the Oxford Technology Park. Equipped with cutting-edge technology, the facilities will drive development of OGT’s trusted SureSeq next generation sequencing (NGS) product portfolio, as well as deliver expert-led training and enhanced opportunities for collaboration.

Roche has entered into an agreement with PathAI, a global leader in artificial intelligence (AI)-powered technology for pathology. Under the terms of this agreement, PathAI will exclusively work with Roche Tissue Diagnostics (RTD) to develop AI-enabled digital pathology algorithms in the companion diagnostics space.

The February issue of Pathology in Practice (PiP) has just been published – please read on to ensure you have the correct and up-to-date version of our app for your Apple or Android device.

Digital and computational pathology solution firm Proscia has announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for its Concentriq AP-Dx. The digital pathology solution was cleared for the purpose of primary diagnosis.

The blood transfusion service in Leeds Teaching Hospitals NHS Trust has started working with a new LIMS, as part of a larger project to deploy a single LIMS across the West Yorkshire Association of Acute Trusts.

Digital pathology firm Paige has announced a significant expansion of its AppLab marketplace, with the addition of six new digital pathology and AI providers. New applications from Imagene, Histofy, Aiosyn, Clinsight, DoMore Diagnostics, and Stratipath, will be added to the AppLab to provide support for pathology laboratories worldwide in building deeply integrated and customised AI-enabled workflows.

Cancer diagnostics company Veracyte has announced it has completed its acquisition of C2i Genomics, adding whole-genome minimal residual disease (MRD) capabilities to its novel diagnostics platform and expanding the company’s ability to serve patients across the cancer care continuum.

Alpha Laboratories has made a further step in its drive to reduce the environmental impact of laboratory consumables with the introduction of FastZAP filter tip refills, which the company says represent a significant step forward in sustainability, while maintaining the quality and performance expected from ZAP premier filter tips.

Beckman Coulter Diagnostics has appointed Kevin O’Reilly as its new president, succeeding Julie Sawyer Montgomery, who is now vice president and group executive at Danaher Diagnostics.